<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>BioMed Central</PublisherName>
    <PublisherLocation>London</PublisherLocation>
    <PublisherImprintName>BioMed Central</PublisherImprintName>
  </PublisherInfo>
  <Journal OutputMedium="Online">
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12865</JournalID>
      <JournalElectronicISSN>1471-2172</JournalElectronicISSN>
      <JournalTitle>BMC Immunology</JournalTitle>
      <JournalSubTitle>BMC series – open, inclusive and trusted</JournalSubTitle>
      <JournalAbbreviatedTitle>BMC Immunol</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="SCB" Type="Primary">Biomedicine</JournalSubject>
        <JournalSubject Code="SCB14000" Priority="1" Type="Secondary">Immunology</JournalSubject>
        <JournalSubject Code="SCH11009" Priority="2" Type="Secondary">Allergology</JournalSubject>
        <JournalSubject Code="SCB16010" Priority="3" Type="Secondary">Vaccine</JournalSubject>
        <JournalSubject Code="SCL14120" Priority="4" Type="Secondary">Cytokines and Growth Factors</JournalSubject>
        <SubjectCollection Code="Biomedical and Life Sciences">SC3</SubjectCollection>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume OutputMedium="Online">
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>17</VolumeIDStart>
        <VolumeIDEnd>17</VolumeIDEnd>
        <VolumeIssueCount>1</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular" OutputMedium="Online">
        <IssueInfo IssueType="Regular" TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>0</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2016</Year>
              <Month>12</Month>
            </CoverDate>
            <PricelistYear>2016</PricelistYear>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>The Author(s)</CopyrightHolderName>
            <CopyrightYear>2016</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="s12865-016-0152-1" OutputMedium="Online">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>152</ArticleID>
            <ArticleDOI>10.1186/s12865-016-0152-1</ArticleDOI>
            <ArticleCitationID>16</ArticleCitationID>
            <ArticleSequenceNumber>16</ArticleSequenceNumber>
            <ArticleTitle Language="En" OutputMedium="All">Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development</ArticleTitle>
            <ArticleCategory>Research article</ArticleCategory>
            <ArticleCollection ID="AC_db520e8fd92b771f07da1d400e48440d" Type="SubjectSection">
              <ArticleCollectionTitle>Cellular immunology and immune regulation</ArticleCollectionTitle>
            </ArticleCollection>
            <ArticleFirstPage>1</ArticleFirstPage>
            <ArticleLastPage>11</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2016</Year>
                <Month>5</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2016</Year>
                <Month>1</Month>
                <Day>14</Day>
              </Received>
              <Accepted>
                <Year>2016</Year>
                <Month>5</Month>
                <Day>23</Day>
              </Accepted>
              <OnlineDate>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>10</Day>
              </OnlineDate>
            </ArticleHistory>
            <ArticleFundingInformation>
              <Fund>
                <FunderName FundRefID="http://dx.doi.org/10.13039/100000050">National Heart, Lung, and Blood Institute</FunderName>
                <GrantNumber GrantRecipient="Au4" Type="FundRef">HL096108</GrantNumber>
              </Fund>
            </ArticleFundingInformation>
            <ArticleCopyright>
              <CopyrightHolderName>The Author(s).</CopyrightHolderName>
              <CopyrightYear>2016</CopyrightYear>
              <License SubType="CC BY + CC0" Type="OpenAccess" Version="4.0">
                <SimplePara>
                           <Emphasis Type="Bold">Open Access</Emphasis>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ExternalRef>
                    <RefSource>http://creativecommons.org/licenses/by/4.0/</RefSource>
                    <RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/>
                  </ExternalRef>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ExternalRef>
                    <RefSource>http://creativecommons.org/publicdomain/zero/1.0/</RefSource>
                    <RefTarget Address="http://creativecommons.org/publicdomain/zero/1.0/" TargetType="URL"/>
                  </ExternalRef>) applies to the data made available in this article, unless otherwise stated.</SimplePara>
              </License>
            </ArticleCopyright>
            <ArticleGrants Type="OpenChoice">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="OpenAccess"/>
              <BodyHTMLGrant Grant="OpenAccess"/>
              <BibliographyGrant Grant="OpenAccess"/>
              <ESMGrant Grant="OpenAccess"/>
            </ArticleGrants>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1 Aff2" ID="Au1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Zhihui</GivenName>
                  <FamilyName>Xu</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2" ID="Au2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Kimberly</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Gwin</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1 Aff3" CorrespondingAffiliationID="Aff3" ID="Au3">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Yulin</GivenName>
                  <FamilyName>Li</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>ylli@mail.jlu.edu.cn</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff2" CorrespondingAffiliationID="Aff2" ID="Au4">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Kay</GivenName>
                  <GivenName>L.</GivenName>
                  <FamilyName>Medina</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>medina.kay@mayo.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>The Key Laboratory Pathobiology, Ministry of Education, Norman Bethune College of Medicine</OrgDivision>
                <OrgName>Jilin University</OrgName>
                <OrgAddress>
                  <City>Changchun</City>
                  <Postcode>130000</Postcode>
                  <Country Code="CN">People’s Republic of China</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgDivision>Department of Immunology, College of Medicine</OrgDivision>
                <OrgName>Mayo Clinic</OrgName>
                <OrgAddress>
                  <Street>200 First Street SW</Street>
                  <City>Rochester</City>
                  <State>MN</State>
                  <Postcode>55905</Postcode>
                  <Country Code="US">USA</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff3">
                <OrgDivision>Department of Pathology, Norman Bethune College of Medicine</OrgDivision>
                <OrgName>Jilin University</OrgName>
                <OrgAddress>
                  <City>Changchun</City>
                  <Postcode>130000</Postcode>
                  <Country Code="CN">People’s Republic of China</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En" OutputMedium="All">
              <Heading>Abstract</Heading>
              <AbstractSection ID="ASec1">
                <Heading>Background</Heading>
                <Para ID="Par1">The serine threonine kinase Pim-1 has documented roles in hematopoietic progenitor and B cell precursor proliferation and survival. Pim-1 is a molecular target of the transcription factor Hoxa9. Previous studies showed that <Emphasis Type="Italic">Pim-1</Emphasis> deficiency phenocopied the hematopoietic progenitor defect in <Emphasis Type="Italic">hoxa9-/-</Emphasis> mice and forced expression of Pim-1 normalized the in vitro proliferation defect inherent to <Emphasis Type="Italic">hoxa9-/-</Emphasis> hematopoietic progenitors. Pim-1 is induced by cytokine signaling, including the early lymphoid/B lineage regulators Flt3 and IL-7, and expression levels were shown to influence the size of the B cell compartment in bone marrow (BM).</Para>
              </AbstractSection>
              <AbstractSection ID="ASec2">
                <Heading>Results</Heading>
                <Para ID="Par2">In this study, we sought to determine if transgenic expression of Pim-1, driven by the immunoglobulin enhancer, <Emphasis Type="Italic">Eμ</Emphasis>, was sufficient to rescue the lymphoid/B cell precursor defect in <Emphasis Type="Italic">hoxa9</Emphasis> or <Emphasis Type="Italic">flt3-ligand</Emphasis> (<Emphasis Type="Italic">flt3l</Emphasis>) deficient mice. Unexpectedly, expression of <Emphasis Type="Italic">Eμ − Pim1</Emphasis> exacerbated lymphoid progenitor deficiencies in <Emphasis Type="Italic">flt3l-/-</Emphasis>, and to a lesser extent, <Emphasis Type="Italic">hoxa9-/-</Emphasis> mice. Furthermore, <Emphasis Type="Italic">Eμ − Pim1</Emphasis> expression alone reduced early myeloid and lymphoid, but not erythroid, progenitors. In contrast, <Emphasis Type="Italic">Pim-1</Emphasis> deficiency had no significant effect on early lymphoid/B cell development through the Pre-Pro-B cell stage, but caused a significant reduction in IgM<Superscript>−</Superscript> B cell precursors. Importantly, loss of <Emphasis Type="Italic">Pim-1</Emphasis> did not phenocopy <Emphasis Type="Italic">hoxa9</Emphasis>- or <Emphasis Type="Italic">flt3l</Emphasis>-deficiency on the lymphoid/early B cell progenitor pools.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec3">
                <Heading>Conclusions</Heading>
                <Para ID="Par3">These experimental findings demonstrate that Pim-1 overexpression has developmental-stage-specific effects on B lymphopoiesis and myelopoiesis. Importantly, these suggest that <Emphasis Type="Italic">Pim-1</Emphasis> deficiency does not contribute significantly to the early lymphoid/B cell developmental deficiency in <Emphasis Type="Italic">hoxa9-/-</Emphasis> or <Emphasis Type="Italic">flt3l</Emphasis>-/- mice.</Para>
              </AbstractSection>
            </Abstract>
            <KeywordGroup Language="En" OutputMedium="All">
              <Heading>Keywords</Heading>
              <Keyword>B cell precursors</Keyword>
              <Keyword>
                        <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgene</Keyword>
              <Keyword>
                <Emphasis Type="Italic">pim1-/-</Emphasis>
              </Keyword>
              <Keyword>Flt3</Keyword>
              <Keyword>Hoxa9</Keyword>
              <Keyword>B cell development</Keyword>
              <Keyword>Lymphopoiesis</Keyword>
              <Keyword>Hematopoiesis</Keyword>
            </KeywordGroup>
          </ArticleHeader>
          <Body>
            <Section1 ID="Sec1">
              <Heading>Background</Heading>
              <Para ID="Par4">The steady-state production of B lineage lymphocytes in bone marrow is contingent on the developmental-stage-specific expression and combinatorial activities of multiple regulatory proteins including transcription factors, signaling molecules, microRNAs, and epigenetic modifiers. A critical early event in B cell development is lymphoid lineage specification within the multipotential progenitor (MPP) pool which we and others have shown is dependent, in part, on the homeodomain transcription factor Hoxa9 and signaling via the receptor tyrosine kinase Flt3 [<CitationRef CitationID="CR1">1</CitationRef>–<CitationRef CitationID="CR4">4</CitationRef>]. Germline knockout of Hoxa9 or Flt3-ligand largely phenocopy each other with respect to reductions in numbers of MPPs, the lymphoid progenitor subsets ALP and BLP, and B cell precursors in BM. Importantly, Hoxa9 and Flt3 signaling function synergistically to regulate a critical early checkpoint in lymphoid development, as combined loss of Hoxa9 and Flt3 signaling ablates the generation of lymphoid primed multipotential progenitors [<CitationRef CitationID="CR4">4</CitationRef>].</Para>
              <Para ID="Par5">Pim-1 is a member of the Pim family of proto-oncogenes that encode a distinct class of serine/threonine kinases. Pim-1 was originally identified as a target for proviral activation in Moloney murine leukemia virus induced T cell lymphomas [<CitationRef CitationID="CR5">5</CitationRef>]. PIM proteins are widely expressed in most tissues and co-expression of family members has been found in various tissues [<CitationRef CitationID="CR6">6</CitationRef>]. The transcription of Pim family members is induced by a variety of cytokines and mitogens that transduce their primary signal through the JAK/STAT pathway [<CitationRef CitationID="CR7">7</CitationRef>]. A role for Pim-1 in B cell development was previously demonstrated through analysis of <Emphasis Type="Italic">pim1-/-</Emphasis> and <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgenic mice [<CitationRef CitationID="CR8">8</CitationRef>, <CitationRef CitationID="CR9">9</CitationRef>]. <Emphasis Type="Italic">Pim1-/-</Emphasis> Pre-B cells exhibited impaired in vitro proliferation in response to IL-7 and stem cell factor (SCF) that was rescued by expression of a functional Pim-1 transgene [<CitationRef CitationID="CR10">10</CitationRef>]. In contrast, overexpression of Pim-1increased numbers of IL-7 + SCF responsive B cell colonies. These combined data provided the first evidence that Pim-1 was an important regulator of B lymphopoiesis in mice, and linked Pim-1 to the IL-7R signaling pathway.</Para>
              <Para ID="Par6">Cytokine signaling plays an essential role in early lymphoid/B cell development. Threshold levels of Flt3 signaling are required for the proliferation, survival, and maintenance of MPPs competent to generate B cell precursors [<CitationRef CitationID="CR1">1</CitationRef>, <CitationRef CitationID="CR11">11</CitationRef>]. Flt3 signaling is mediated by the Ras and STAT5 pathways [<CitationRef CitationID="CR12">12</CitationRef>]. A dominant negative form of Ras was shown to phenocopy the B lineage developmental block in <Emphasis Type="Italic">flt3-/-</Emphasis> mice, impairing the proliferation of common lymphoid progenitors and Pre-Pro-B cells. The same study showed that Ras promoted STAT5-dependent Pro-B differentiation by enhancing expression of IL-7Rα [12]. Pim-1 is induced downstream of Jak2/STAT5 signaling and has also been implicated in playing a role in the proliferation and/or differentiation of myeloid progenitors [<CitationRef CitationID="CR13">13</CitationRef>–<CitationRef CitationID="CR15">15</CitationRef>]. Importantly, a role for Pim-1 in regulation of the early lymphoid/B cell progenitor pool, prior to expression of CD45R/B220, has not been reported.</Para>
              <Para ID="Par7">Functional studies have confirmed a role for Pim-1 in regulating hematopoietic stem cell (HSC) proliferation and survival. HSCs from <Emphasis Type="Italic">pim1-/-</Emphasis> mice exhibited impaired repopulating capacity in competitive transplantation experiments [<CitationRef CitationID="CR16">16</CitationRef>]. In vitro assays revealed decreased cytokine mediated cell growth and differentiation of hematopoietic progenitors [<CitationRef CitationID="CR7">7</CitationRef>]. In contrast, overexpression of human Pim-1 driven by <Emphasis Type="Italic">vav</Emphasis> hematopoietic regulatory elements and SV40 showed enhanced hematopoietic progenitor function in vitro and in vivo [<CitationRef CitationID="CR16">16</CitationRef>]. The hematopoietic defects exhibited by <Emphasis Type="Italic">pim1-/-</Emphasis> mice are strikingly similar to those in <Emphasis Type="Italic">hoxa9-/-</Emphasis> mice as loss of <Emphasis Type="Italic">hoxa9</Emphasis> also impaired the proliferation and repopulating ability of HSCs [<CitationRef CitationID="CR17">17</CitationRef>]. Consistent with this observation, <Emphasis Type="Italic">pim1</Emphasis> is a direct target of Hoxa9 [<CitationRef CitationID="CR18">18</CitationRef>]. Somatic ablation of <Emphasis Type="Italic">pim1</Emphasis>, <Emphasis Type="Italic">hoxa9</Emphasis>, or <Emphasis Type="Italic">flt3</Emphasis> causes select reductions in hematopoietic progenitor subsets and B cell precursors. However, an obligate role for Pim-1 in regulation of lymphoid and/or early B cell development has not been investigated. In this study we evaluated the role of Pim-1 in murine lymphoid lineage specification and B cell development through comparative flow cytometric analysis of <Emphasis Type="Italic">hoxa9-/- x Eμ-Pim1</Emphasis>Tg, <Emphasis Type="Italic">flt3l-/- x Eμ-Pim1</Emphasis>Tg, <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgenic, <Emphasis Type="Italic">pim1-/-</Emphasis>, <Emphasis Type="Italic">hoxa9-/-,</Emphasis> and <Emphasis Type="Italic">flt3l-/-</Emphasis> mice. Our experimental findings revealed that Pim-1 dysregulation has developmental-stage-specific effects on B lymphopoiesis and early myeloid, but not erythroid progenitors. Furthermore, we show that <Emphasis Type="Italic">Pim1-</Emphasis>deficiency is not the basis of the lymphoid or early B cell developmental defects in <Emphasis Type="Italic">hoxa9-/- or flt3l-/-</Emphasis> mice.</Para>
            </Section1>
            <Section1 ID="Sec2">
              <Heading>Methods</Heading>
              <Section2 ID="Sec3">
                <Heading>Mice</Heading>
                <Para ID="Par8">Wildtype C57Bl/6 mice were generated from our breeding colony. <Emphasis Type="Italic">Pim1-/-</Emphasis> and <Emphasis Type="Italic">Eμ − Pim1</Emphasis> transgenic mice have been previously described [<CitationRef CitationID="CR10">10</CitationRef>]. <Emphasis Type="Italic">Pim1-/-</Emphasis> mice were provided by Andrew S. Kraft and <Emphasis Type="Italic">Eμ − Pim1</Emphasis> transgenic mice were provided by Jung-Hyun Park and permission for both obtained from A. Berns. All mice evaluated in this study were 8–12 weeks of age. C57Bl/6, <Emphasis Type="Italic">EμPim-1</Emphasis>Tg, <Emphasis Type="Italic">hoxa9-/- x Eμ-Pim1</Emphasis>Tg, and <Emphasis Type="Italic">flt3l-/- x Eμ-Pim1</Emphasis>Tg mice were bred in the Mayo Clinic animal facility, and all animal experiments detailed in this study were conducted under guidelines established and approved by the Mayo Clinic Institutional Animal Care and Use Committee. PCR, using DNA isolated from tail clips, was performed using previously published primers to confirm the genotype of compound mice [<CitationRef CitationID="CR19">19</CitationRef>, <CitationRef CitationID="CR20">20</CitationRef>].</Para>
              </Section2>
              <Section2 ID="Sec4">
                <Heading>Flow cytometric analysis of BM hematopoietic progenitor subsets and B cell precursors</Heading>
                <Para ID="Par9">Methods for flow cytometry and progenitor isolation have been described [<CitationRef CitationID="CR4">4</CitationRef>]. Flow cytometric analysis was performed on the FACS-Canto or LSRII cytometers (BD BioSciences, San Jose, CA) and data analysis performed with FlowJo software (Tree Star, Ashland, OR). All antibodies used in this study were purchased from eBioScience or Biolegend. HSC/MPPs were resolved using the following combinations of antibodies: Lineage positive APC cocktail (CD3ε, Ter119, B220, Mac-1, Gr-1), CD34 FITC, Flt3 PE, Sca-1 PerCP-Cy5.5, CD150 PE-Cy7, c-kit APC-eflour 780 and 1.5×10<Superscript>6</Superscript> million events collected for the analysis. MEPs, CMPs, and GMPs were resolved using the following combinations of antibodies: Lineage positive APC cocktail (CD3e, Ter119, B220, Mac-1, Gr-1), CD34 FITC, Flt3 PE, Sca-1 PerCP-Cy5.5, c-kit APC-eflour 780 and 1.5 × 10<Superscript>6</Superscript> million events collected for the analysis. ALP and BLP were resolved using the following combinations of antibodies: Lineage positive FITC cocktail (CD3ε, CD8α, CD11c, NK1.1, Ly6C, Ter119, B220, Mac-1, Gr-1), Flt3 PE, IL-7R PE-Cy7, Ly6D AF647, c-kit APC-eflour 780, PDCA1 PerCP-eflour 710 and 2×10<Superscript>6</Superscript> million events collected for the analysis. Pre-Pro-B and BCP subsets were resolved using the following combinations of antibodies: B220 FITC, AA4.1 PE, PDCA1 PerCP-eflour 710, CD19 Pe-Cy7, Ly6D AF647, and IgM APC-Cy7 and 500,000 to 1 × 10<Superscript>6</Superscript> million events collected for the analysis. Red blood cells and cellular debris were excluded from the analysis with mononuclear cell and doublet exclusion gates. Absolute cell numbers were determined by multiplying population frequencies (total subset event count divided by total event count) times mononuclear cell count. Cell counts reflect numbers of cells per 4 hindlimb leg bones.</Para>
              </Section2>
              <Section2 ID="Sec5">
                <Heading>Realtime RT-PCR analysis of <Emphasis Type="Italic">pim1</Emphasis> transcript levels in bone marrow progenitor subsets</Heading>
                <Para ID="Par10">Hematopoietic progenitor subsets were purified by cell sorting for RNA isolation, cDNA synthesis, and qPCR analysis as we previously described [<CitationRef CitationID="CR21">21</CitationRef>]. HSC/MPP were purified as Lin<Superscript>−</Superscript> (see Lin<Superscript>+</Superscript> cocktail above) c-kit<Superscript>hi</Superscript> Sca-1<Superscript>+</Superscript> Flt3<Superscript>-lo</Superscript>, LMPP as Lin<Superscript>−</Superscript> c-kit<Superscript>hi</Superscript> Sca-1<Superscript>+</Superscript> Flt3<Superscript>hi</Superscript>, CLP as Lin<Superscript>−</Superscript> c-kit<Superscript>lo</Superscript> IL-7R<Superscript>+</Superscript> Sca-1<Superscript>+</Superscript> Flt3<Superscript>+</Superscript>, Pre-Pro-B as B220<Superscript>+</Superscript> CD43<Superscript>+</Superscript> CD19<Superscript>−</Superscript> IgM<Superscript>−</Superscript> (which includes a mix of Pre-Pro-B, NK, and pDCs), Pro-B as B220<Superscript>+</Superscript> CD43<Superscript>+</Superscript> CD19<Superscript>+</Superscript> IgM<Superscript>−</Superscript>, Pre-B as B220<Superscript>+lo</Superscript> CD43<Superscript>−</Superscript> CD19<Superscript>+</Superscript> IgM<Superscript>−</Superscript>, and IgM<Superscript>+</Superscript> as B220<Superscript>+hi</Superscript> CD43<Superscript>−</Superscript> CD19<Superscript>+</Superscript> IgM<Superscript>+</Superscript>. Realtime PCR was performed using a <Emphasis Type="Italic">pim1</Emphasis> taqman probe (Mm00435712_m1) and gene expression normalized to 18S RNA. All cDNA samples were assayed in triplicate. Relative transcript abundance was determined using the 2<Superscript>-ΔΔCT</Superscript> method.</Para>
              </Section2>
              <Section2 ID="Sec6">
                <Heading>Statistics</Heading>
                <Para ID="Par11">Statistical significance was determined using the Student-<Emphasis Type="Italic">t</Emphasis> test. Data are reported as standard error of the mean (SEM) and <Emphasis Type="Italic">p</Emphasis>-values less than 0.05 were considered significant.</Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec7">
              <Heading>Results</Heading>
              <Section2 ID="Sec8">
                <Heading>Forced expression of Pim-1 does not rescue the lymphoid/B lineage deficiency in <Emphasis Type="Italic">hoxa9-/-</Emphasis> or <Emphasis Type="Italic">flt3l-/-</Emphasis> mice</Heading>
                <Para ID="Par12">Gene-targeted ablation of <Emphasis Type="Italic">pim1</Emphasis>, <Emphasis Type="Italic">hoxa9</Emphasis>, or <Emphasis Type="Italic">flt3</Emphasis> causes reductions in select hematopoietic progenitor subsets and B cell precursors. Pim-1 is a molecular target of Hoxa9 and has been shown to be induced by Flt3 signaling [<CitationRef CitationID="CR18">18</CitationRef>, <CitationRef CitationID="CR22">22</CitationRef>]. To determine if dysregulated expression of Pim-1 contributed to the lymphoid/B lineage precursor deficiency in <Emphasis Type="Italic">hoxa9-/-</Emphasis> or <Emphasis Type="Italic">flt3l-/-</Emphasis> mice, <Emphasis Type="Italic">hoxa9-/- x Eμ-Pim1</Emphasis>Tg and <Emphasis Type="Italic">flt3l-/- x Eμ-Pim1</Emphasis>Tg mice were generated. Transgenic expression of <Emphasis Type="Italic">Eμ-Pim1</Emphasis> had no significant effect on BM cellularity in <Emphasis Type="Italic">hoxa9-/-</Emphasis> or <Emphasis Type="Italic">flt3l-/-</Emphasis> mice (data not shown). <Emphasis Type="Italic">Hoxa9-/-</Emphasis> and <Emphasis Type="Italic">flt3l-/-</Emphasis> mice have significantly decreased numbers of Lin<Superscript>−</Superscript> c-kit<Superscript>lo</Superscript> IL-7R<Superscript>+</Superscript> common lymphoid progenitors (CLPs) [<CitationRef CitationID="CR4">4</CitationRef>]. CLPs can be fractionated into Lin<Superscript>−</Superscript> PDCA1<Superscript>−</Superscript> IL-7R<Superscript>+</Superscript> c-kit<Superscript>lo</Superscript> Flt3<Superscript>+</Superscript> Ly6D<Superscript>−</Superscript> all lymphoid progenitors (ALP) and Lin<Superscript>−</Superscript> PDCA1<Superscript>−</Superscript> IL-7R<Superscript>+</Superscript> c-kit<Superscript>lo</Superscript> Flt3<Superscript>+</Superscript> Ly6D<Superscript>+</Superscript> B lymphoid progenitors (BLP) [<CitationRef CitationID="CR23">23</CitationRef>]. <Emphasis Type="Italic">Eμ</Emphasis> transgene driven expression of Pim-1 did not exacerbate the deficiencies in ALP or BLP in <Emphasis Type="Italic">hoxa9-/-</Emphasis> mice (Fig. <InternalRef RefID="Fig1">1a–c</InternalRef>). However, <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg expression did exacerbate the reductions in ALP and BLP in <Emphasis Type="Italic">flt3l-/-</Emphasis> mice (Fig. <InternalRef RefID="Fig1">1a–c</InternalRef>). Expression of B220 distinguishes Pre-Pro-B cells from BLP [<CitationRef CitationID="CR23">23</CitationRef>]. Consistent with reductions in ALP and BLP, numbers of PDCA1<Superscript>−</Superscript> Ly6D<Superscript>+</Superscript> B220<Superscript>+</Superscript> CD19<Superscript>−</Superscript> Pre-Pro-B cells were reduced in <Emphasis Type="Italic">hoxa9-/- x Eμ-Pim1</Emphasis>Tg and <Emphasis Type="Italic">flt3l-/- x Eμ-Pim1</Emphasis>Tg mice compared to WT (Fig. <InternalRef RefID="Fig2">2a–b</InternalRef>). However, in contrast to ALP and BLP, <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg expression did not abrogate the Pre-Pro-B cell deficiency <Emphasis Type="Italic">hoxa9-/-</Emphasis> or <Emphasis Type="Italic">flt3l-/-</Emphasis> mice (Fig. <InternalRef RefID="Fig2">2a–b</InternalRef>). The B lineage committed progeny of Pre-Pro-B cells are IgM<Superscript>−</Superscript> B220<Superscript>+</Superscript> CD19<Superscript>+</Superscript> B cell precursors (BCPs). Unlike the negative impact of <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgene expression on CLP subsets and Pre-Pro-B cells, no statistically significant reduction in IgM<Superscript>−</Superscript> B220<Superscript>+</Superscript> CD19<Superscript>+</Superscript> BCPs or total IgM<Superscript>+</Superscript> B cells was found in <Emphasis Type="Italic">hoxa9-/- x Eμ-Pim1</Emphasis>Tg (Fig.<InternalRef RefID="Fig2"> 2a,c–d</InternalRef>). However, reductions in IgM<Superscript>−</Superscript> B220<Superscript>+</Superscript> CD19<Superscript>+</Superscript> BCP and total IgM<Superscript>+</Superscript> B cell compartments were maintained in <Emphasis Type="Italic">flt3l-/-</Emphasis> and <Emphasis Type="Italic">flt3l-/- x Eμ-Pim1</Emphasis>Tg mice (Fig. <InternalRef RefID="Fig2">2a,c–d</InternalRef>). These data reveal a previously uncharacterized inhibitory effect of <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg expression on early lymphoid/B cell development.<Figure Category="Standard" Float="Yes" ID="Fig1">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 1</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Forced expression of Pim-1 does not rescue the lymphoid deficiency in <Emphasis Type="Italic">hoxa9-/-</Emphasis> or <Emphasis Type="Italic">flt3l-/-</Emphasis> mice. <Emphasis Type="Bold">a</Emphasis> Flow cytometry profile and gating strategy for ALP and BLP in the various mouse strains. <Emphasis Type="Bold">b</Emphasis> Bar graph depicting absolute numbers of ALP in the various mice. <Emphasis Type="Bold">c</Emphasis> Bar graph depicting absolute numbers of BLP in the various mice. Data represents the mean ± SEM of 4–10 mice per group. A single asterisk * denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.05 and ** denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.005. To determine statistical significance, comparisons were made to WT, or between select comparators indicated by the line</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO1">
                      <ImageObject Color="Color" FileRef="MediaObjects/12865_2016_152_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                           <Figure Category="Standard" Float="Yes" ID="Fig2">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 2</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Effect of <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg expression on B cell subsets in bone marrow. <Emphasis Type="Bold">a</Emphasis> Flow cytometric analysis of Pre-Pro-B, CD19<Superscript>+</Superscript> cells, IgM<Superscript>-lo</Superscript> B cells (which includes BCPs and recirculating B cells), and IgM<Superscript>+hi</Superscript> naïve B cells in the various mouse strains. <Emphasis Type="Bold">b-e</Emphasis> Graphs depicting absolute numbers of (<Emphasis Type="Bold">b</Emphasis>) Pre-Pro-B cells, (<Emphasis Type="Bold">c</Emphasis>) CD19<Superscript>+</Superscript> cells, (<Emphasis Type="Bold">d</Emphasis>) IgM<Superscript>-lo</Superscript> B cells, and (<Emphasis Type="Bold">e</Emphasis>) IgM<Superscript>+</Superscript> BCPs. Data represents the mean ± SEM of 4–10 mice per group. * denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.05 and ** denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.005</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO2">
                      <ImageObject Color="Color" FileRef="MediaObjects/12865_2016_152_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
              </Section2>
              <Section2 ID="Sec9">
                <Heading>Impact of Pim1-deficiency versus <Emphasis Type="Italic">Eμ −</Emphasis> transgene driven expression of Pim-1 on BM lymphoid progenitors and BCPs</Heading>
                <Para ID="Par13">A role for Pim-1 in B cell development was previously demonstrated from analysis of <Emphasis Type="Italic">pim1-/-</Emphasis> and <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgenic mice [<CitationRef CitationID="CR10">10</CitationRef>]. Our findings that <Emphasis Type="Italic">Eμ</Emphasis> transgene driven expression of Pim-1 abrogated lymphoid/early B cell development supported further evaluation of the effects of dysregulated expression of Pim-1 on development of this lineage. BM cells from WT, <Emphasis Type="Italic">pim1-/-</Emphasis>, and <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgenic mice were stained with combinations of antibodies to resolve ALP, BLP, Pre-Pro-B, IgM<Superscript>−</Superscript> BCP, and IgM<Superscript>+</Superscript> B cells. Comparison of BM mononuclear cell counts revealed no significant difference between WT and <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgenic mice, but a statistically significant reduction in <Emphasis Type="Italic">pim1-/-</Emphasis> mice (5.2×10<Superscript>7</Superscript> ± 0.33, <Emphasis Type="Italic">n</Emphasis> = 3; <Emphasis Type="Italic">p</Emphasis> = 0.0055) compared to WT (7.9 ×10<Superscript>7</Superscript> ± 1.3, <Emphasis Type="Italic">n</Emphasis> = 10). No statistically significant alterations in absolute numbers of ALP, BLP, or Pre-Pro-B were identified between WT and <Emphasis Type="Italic">pim1-/-</Emphasis> mice (Fig. <InternalRef RefID="Fig3">3a</InternalRef>). The inverse was found in <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgenic mice wherein absolute numbers of phenotypic ALP, BLP, and Pre-Pro-B cells were significantly reduced compared to WT (Fig. <InternalRef RefID="Fig3">3a</InternalRef>). Finally, while numbers of IgM<Superscript>−</Superscript> BCP and IgM<Superscript>+</Superscript> B cells in <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgenic mice were comparable to WT (Fig. <InternalRef RefID="Fig3">3a</InternalRef>), we found that IgM<Superscript>−</Superscript>, but not IgM<Superscript>+</Superscript>, BCPs were reduced in <Emphasis Type="Italic">pim1-/-</Emphasis> mice [<CitationRef CitationID="CR10">10</CitationRef>]. CD19<Superscript>+</Superscript> IgM<Superscript>−</Superscript> BCPs constitute Pro-B and Pre-B cells. To gain further insight into the role of Pim-1 in hematopoietic development and B cell differentiation, we evaluated <Emphasis Type="Italic">pim-1</Emphasis> transcript levels in purified bone marrow progenitor subsets. As shown in Fig. <InternalRef RefID="Fig3">3b</InternalRef>, abundant <Emphasis Type="Italic">pim-1</Emphasis> transcript expression was high exclusively in Pre-B cells across the B lineage developmental spectrum. Taken together, these data suggest that elevated levels of Pim-1 are inhibitory for lymphoid/B cell development prior to commitment to the B cell fate. On the other hand, loss of Pim-1 decreased IgM<Superscript>−</Superscript> Pro-B/Pre-B cells, suggesting an essential role at this stage.<Figure Category="Standard" Float="Yes" ID="Fig3">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 3</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Impact of <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg or <Emphasis Type="Italic">Pim1</Emphasis>-deficiency on lymphoid progenitor and B cell precursor subsets in bone marrow. <Emphasis Type="Bold">a</Emphasis> Bar graphs depicting absolute numbers of ALP, BLP, Pre-Pro-B, IgM<Superscript>−</Superscript> B cell precursors, and IgM<Superscript>+</Superscript> B cells. Data represents the mean ± SEM of 3–10 mice per group. * denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.05 and ** denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.005. <Emphasis Type="Bold">b</Emphasis> Realtime PCR analysis of <Emphasis Type="Italic">pim-1</Emphasis> transcript levels in sorted hematopoietic progenitor and B cell subsets with HSC/MPP designated as the comparator</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO3">
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/12865_2016_152_Fig3_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
              </Section2>
              <Section2 ID="Sec10">
                <Heading>Impact of Pim1-deficiency versus <Emphasis Type="Italic">Eμ −</Emphasis> transgene driven expression of Pim-1 on HSC, MPP, and erythroid/myeloid progenitors</Heading>
                <Para ID="Par14">The <Emphasis Type="Italic">Eμ</Emphasis> enhancer is active very early in hematopoiesis, within LSK<Superscript>+</Superscript> MPPs [<CitationRef CitationID="CR11">11</CitationRef>, <CitationRef CitationID="CR24">24</CitationRef>]. A previous study reported increased numbers of LSK<Superscript>+</Superscript> cells in <Emphasis Type="Italic">vav-Pim1Tg</Emphasis> mice, but a similar analysis has not been reported for <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg mice [<CitationRef CitationID="CR16">16</CitationRef>]<Emphasis Type="Italic">.</Emphasis> To begin, we compared frequencies of LSK<Superscript>+</Superscript> cells. In contrast to results reported for <Emphasis Type="Italic">vav-Pim1Tg</Emphasis> mice, frequencies and numbers of total LSK<Superscript>+</Superscript> cells were significantly reduced in <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg mice (Fig. <InternalRef RefID="Fig4">4a–b</InternalRef> and data not shown). Next we compared frequencies and numbers of LSK<Superscript>+</Superscript> CD150<Superscript>+</Superscript> CD34<Superscript>−</Superscript> HSC and LSK<Superscript>+</Superscript> CD150<Superscript>−</Superscript> Flt3<Superscript>+</Superscript> MPP in <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg mice. Absolute numbers of HSC and MPP were significantly reduced in <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg mice (Fig. <InternalRef RefID="Fig4">4c–d</InternalRef>). However, the reduction was attributed to the total decrease in LSK<Superscript>+</Superscript> cells as percentages of CD150<Superscript>+</Superscript> CD34<Superscript>−</Superscript> HSC within the LSK<Superscript>+</Superscript> compartment were increased in <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg mice (6.23 ± 0.990 vs. 4.05 ± 1.07 %, <Emphasis Type="Italic">p</Emphasis> = 0.014, in <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg vs. WT, respectively)<Emphasis Type="Italic">.</Emphasis> The same was true for the reduction in absolute numbers of MPP as percentages CD150<Superscript>−</Superscript> Flt3<Superscript>+</Superscript> within the LSK<Superscript>+</Superscript> compartment was not significantly reduced (73.7 ± 4.53 vs. 80.1 ± 3.72 %, <Emphasis Type="Italic">p</Emphasis> = 0.064, in <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg vs. WT, respectively)<Emphasis Type="Italic">.</Emphasis> The reduction in LSK<Superscript>+</Superscript> cells in <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg mice could influence numbers of erythroid/myeloid progenitors. Frequencies of Lin<Superscript>−</Superscript> ckit<Superscript>hi</Superscript> Sca1<Superscript>−</Superscript> cells were not altered in <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg mice (Fig. <InternalRef RefID="Fig4">4a</InternalRef>). However, significant alterations in frequencies and absolute numbers of CMP and GMP, but not MEP, were documented <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg mice (Fig. <InternalRef RefID="Fig4">4a,e–m</InternalRef>). No significant alterations in frequencies or numbers of LSK<Superscript>+</Superscript>, HSC, MPP, CMP, MEP, or GMP were observed in <Emphasis Type="Italic">pim1-/-</Emphasis> mice, compared to WT (Fig. <InternalRef RefID="Fig4">4</InternalRef>). Taken together, these data show that <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg driven expression of Pim-1, but not <Emphasis Type="Italic">Pim1</Emphasis>-deficiency, reduces the myeloid but not the erythroid/megakaryocytic progenitor pools.<Figure Category="Standard" Float="Yes" ID="Fig4">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 4</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Impact of <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg or <Emphasis Type="Italic">Pim1</Emphasis>-deficiency on primitive hematopoietic and myeloid-erythroid progenitor subsets in bone marrow. <Emphasis Type="Bold">a</Emphasis> Flow cytometry profile and gating strategy for HSC, Flt3+ MPP, CMP, GMP, and MEP. Bar graphs depict absolute numbers or frequencies of the various progenitor subsets. <Emphasis Type="Bold">b</Emphasis> Percentage of LSK+ in total BM. <Emphasis Type="Bold">c–d</Emphasis> Absolute number of HSC or MPP in BM. <Emphasis Type="Bold">e–g</Emphasis> Frequencies of CMP, MEP, or GMP within the Lin- ckithi Sca1- subset. <Emphasis Type="Bold">h–j</Emphasis> Absolute numbers of CMP, MEP, or GMP in BM. <Emphasis Type="Bold">k–m</Emphasis> Frequencies of CMP, MEP, or GMP in BM. Data represents the mean ± SEM of 3–10 mice per group. * denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.05 and ** denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.005</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO4">
                      <ImageObject Color="Color" FileRef="MediaObjects/12865_2016_152_Fig4_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
              </Section2>
              <Section2 ID="Sec11">
                <Heading>Loss of Pim-1 does not phenocopy <Emphasis Type="Italic">hoxa9-</Emphasis> deficiency on the lymphoid/early B cell progenitor pools</Heading>
                <Para ID="Par15">Pim-1 is a Hoxa9 target gene and forced expression of Pim-1 rescued the in vitro proliferation of <Emphasis Type="Italic">hoxa9-/-</Emphasis> BM progenitors [<CitationRef CitationID="CR18">18</CitationRef>]. We reasoned that if <Emphasis Type="Italic">Pim1</Emphasis>-deficiency is the basis of the hematopoietic progenitor defect in <Emphasis Type="Italic">hoxa9-/-</Emphasis> mice, then <Emphasis Type="Italic">pim1-/-</Emphasis> mice should phenocopy, at least in part, <Emphasis Type="Italic">hoxa9-/-</Emphasis> progenitor defects in BM. <Emphasis Type="Italic">Hoxa9-/-</Emphasis> and <Emphasis Type="Italic">pim1-/-</Emphasis> mice shared statistically significantly increased frequencies of HSCs. However, while <Emphasis Type="Italic">hoxa9-/-</Emphasis> and <Emphasis Type="Italic">flt3l-/-</Emphasis> mice shared similar reductions in CMP, GMP, ALP, BLP, and Pre-Pro-B cells, consistent with our previous observation, loss of <Emphasis Type="Italic">Pim-1</Emphasis> did not phenocopy <Emphasis Type="Italic">Hoxa9</Emphasis>-deficiency (Fig. <InternalRef RefID="Fig5">5</InternalRef>) [<CitationRef CitationID="CR4">4</CitationRef>, <CitationRef CitationID="CR23">23</CitationRef>].<Figure Category="Standard" Float="Yes" ID="Fig5">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 5</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Comparison of <Emphasis Type="Italic">Hoxa9-</Emphasis>, <Emphasis Type="Italic">Fl3tl-</Emphasis>, and <Emphasis Type="Italic">Pim1-</Emphasis>deficiencies on hematopoietic progenitor subsets and Pre-Pro-B cells. Bar graphs depict absolute numbers of the various progenitor subsets. Data represents the mean ± SEM of 3–4 mice per single knockout and 10 WT mice. * denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.05 and ** denotes <Emphasis Type="Italic">p</Emphasis> &lt; 0.005</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject ID="MO5">
                      <ImageObject Color="BlackWhite" FileRef="MediaObjects/12865_2016_152_Fig5_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                    </MediaObject>
                  </Figure>
                        </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec12">
              <Heading>Discussion</Heading>
              <Para ID="Par16">Previous studies have implicated a role for Pim-1 in regulation of B cell development in BM and <Emphasis Type="Italic">pim-1</Emphasis> is a Hoxa9 target gene [<CitationRef CitationID="CR10">10</CitationRef>, <CitationRef CitationID="CR18">18</CitationRef>]. Furthermore, <Emphasis Type="Italic">hoxa9-</Emphasis> and <Emphasis Type="Italic">pim1-</Emphasis>deficient mice share similar hematopoietic phenotypes and forced expression of Pim-1 rescued the in vitro proliferation defect in <Emphasis Type="Italic">hoxa9-/-</Emphasis> BM progenitors [<CitationRef CitationID="CR17">17</CitationRef>, <CitationRef CitationID="CR18">18</CitationRef>]. To determine if forced expression of Pim-1 was sufficient to restore the lymphoid progenitor/B cell precursor defect in <Emphasis Type="Italic">hoxa9-/-</Emphasis> or <Emphasis Type="Italic">flt3l-/-</Emphasis> mice, we generated <Emphasis Type="Italic">hoxa9-/- Eμ-Pim1</Emphasis>Tg mice and <Emphasis Type="Italic">flt3l-/- Eμ-Pim1</Emphasis>Tg mice. Unexpectedly, <Emphasis Type="Italic">Eμ</Emphasis> driven expression of Pim-1 exacerbated the deficiencies in ALP and BLP in <Emphasis Type="Italic">flt3l-/-,</Emphasis> but not <Emphasis Type="Italic">hoxa9-/-</Emphasis> mice. The detrimental effect in <Emphasis Type="Italic">flt3l-/- Eμ-Pim1</Emphasis>Tg mice was specific to the ALP and BLP stages of B cell differentiation, as the <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg did not further exacerbate the B cell deficiencies in <Emphasis Type="Italic">flt3l-/-</Emphasis> mice from the Pre-Pro-B through the IgM<Superscript>+</Superscript> stages. The negative effect of <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg expression was not restricted to the ALP and BLP compartments. We previously showed that <Emphasis Type="Italic">Eμ</Emphasis> is active from a very early stage in hematopoiesis and here we also show that <Emphasis Type="Italic">Eμ-Pim1</Emphasis>Tg expression caused significant reductions in numbers of HSCs, MPPs, CMPs, and GMPs suggesting that Pim-1 expression levels must be carefully controlled during early hematopoietic differentiation [<CitationRef CitationID="CR11">11</CitationRef>, <CitationRef CitationID="CR24">24</CitationRef>]. In contrast, loss of Pim-1, which we hypothesized might have deleterious consequences on the early lymphoid/B cell progenitor pools, was dispensable for hematopoiesis with the exception of IgM<Superscript>−</Superscript> BCPs [<CitationRef CitationID="CR10">10</CitationRef>]. Consistent, with our findings, realtime PCR of <Emphasis Type="Italic">pim-1</Emphasis> transcription across the hematopoietic spectrum, showed significant levels limited to BCPs at the Pre-B cell stage. Finally, through direct comparative hematopoietic progenitor subset analysis of <Emphasis Type="Italic">hoxa9-/-</Emphasis>, <Emphasis Type="Italic">flt3l-/-</Emphasis>, and <Emphasis Type="Italic">pim1-/-</Emphasis> mice, we suggest that loss of Pim-1 is unlikely to contribute significantly to the hematopoietic progenitor defects in either <Emphasis Type="Italic">hoxa9-/-</Emphasis> or <Emphasis Type="Italic">flt3l-/-</Emphasis> mice. Taken together, these comprehensive flow cytometric analyses demonstrate very select lineage and developmental-stage-specific consequences of dysregulated expression of Pim-1 expression on BM hematopoietic progenitor and B lineage subsets.</Para>
              <Para ID="Par17">The serine threonine phosphokinase Pim-1 is highly expressed in hematopoietic cells in mouse and man [<CitationRef CitationID="CR20">20</CitationRef>, <CitationRef CitationID="CR25">25</CitationRef>]. The <Emphasis Type="Italic">pim-1</Emphasis> gene was originally discovered as a common insertion site in MoMuLV-induced T cell lymphomas and later found in B-cell lymphomas and erythroleukemias. Overexpression of Pim-1 driven by the <Emphasis Type="Italic">Eμ</Emphasis> enhancer was shown to lead to a low incidence of T cell lymphomas and increased sensitivity to chemically induced T cell transformation. In the B lineage, overexpression of <Emphasis Type="Italic">Eμ −</Emphasis> Pim-1 facilitated establishment of B cell progenitor cell lines blocked at the Pre-B cell stage of differentiation [<CitationRef CitationID="CR10">10</CitationRef>]. The same study reported that marrows with the highest Pim-1 expression had a reduction in M-CSF responsive cells, and suggested the result could be due to impaired macrophage differentiation or on a macrophage progenitor. Our immunophenotypic analysis of <Emphasis Type="Italic">Eμ-Pim1</Emphasis> transgenic mice provides insight into the reductions in M-CSF responsive cells as we identified significant reductions in frequencies and absolute numbers of CMP and GMP.</Para>
              <Para ID="Par18">PIM kinases are short-lived proteins induced at the level of transcription upon mitogenic stimulation [<CitationRef CitationID="CR26">26</CitationRef>]. They do not have regulatory domains and are constitutively active when expressed. Under physiologic conditions, their short half-life limits their activity [<CitationRef CitationID="CR27">27</CitationRef>]. Many cytokines that induce <Emphasis Type="Italic">pim</Emphasis> gene transcription act through the JAK/STAT pathway. The <Emphasis Type="Italic">pim1</Emphasis> promoter has binding sites for STAT3 and STAT5 [<CitationRef CitationID="CR28">28</CitationRef>, <CitationRef CitationID="CR29">29</CitationRef>]. Pim-1 protein then, in turn, functions to inhibit the JAK/STAT pathway by binding and activating SOCS proteins [<CitationRef CitationID="CR30">30</CitationRef>]. SOCS proteins support cytokine signaling through the Ras/MAPK pathway by binding the Ras inhibitor RasGAP [<CitationRef CitationID="CR30">30</CitationRef>]. Interestingly, dysregulated Ras/SOCS function mediated by overexpression of Pim-1 provides a plausible cellular mechanism for the impaired lymphoid/early B lineage development exhibited by <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg mice. Ras proteins are involved in regulating proliferation and differentiation of various cell types in a tissue specific manner. Pertinent to this study, mice expressing a dominant negative form of human H-Ras have a severe block in B cell development at the Pre-Pro-B to Pro-B transition [<CitationRef CitationID="CR31">31</CitationRef>]. Li, et al., previously showed that a Flt3/Ras dependent signal governs lymphoid progenitor (ALP + BLP) and Pre-Pro-B proliferation [<CitationRef CitationID="CR12">12</CitationRef>]. In addition, they showed that Flt3/Ras suppresses expression of <Emphasis Type="Italic">socs2</Emphasis> and <Emphasis Type="Italic">socs3</Emphasis>. They concluded that Flt3 activation of Ras primes B cell development by inducing a state of STAT5 responsiveness, a key event downstream of IL-7R signaling in lymphoid progenitors leading to induction of the B cell fate specification and commitment factor EBF1. Sustained expression of Pim-1 would be predicted to stabilize SOCS expression, impairing STAT5-mediated induction of <Emphasis Type="Italic">ebf1</Emphasis>, suppressing EBF1-directed B cell differentiation. Indeed, this hypothetical molecular explanation is consistent with our findings that the Flt3 dependent ALP and BLP stages are exquisitely sensitive to dysregulated Pim-1 in <Emphasis Type="Italic">flt3l-/-</Emphasis> mice. It also suggests that it is unlikely that elevated levels of Pim-1 are inhibitory for lymphoid/B cell development by accelerating B cell differentiation, given the critical role for STAT5/EBF1 in this process.</Para>
              <Para ID="Par19">Pim kinases act as oncogenes by promoting cell cycle progression by phosphorylating and down-regulating the cyclin dependent kinase inhibitor p27Kip1. Pim kinases also have the ability to suppress <Emphasis Type="Italic">p27kip1</Emphasis> transcription through phosphorylation and inactivation of forkhead transcription factors, including FoxO1 and FoxO3 [<CitationRef CitationID="CR32">32</CitationRef>]. Pim-1 inactivation of FoxO1 would have deleterious effects on B cell fate determination as FoxO1 is an integral member of a global network of transcription factors, including E2A and EBF1 [<CitationRef CitationID="CR33">33</CitationRef>]. Importantly, <Emphasis Type="Italic">FoxO1</Emphasis>-deficient mice also have an arrest in B cell development at the CLP stage, specifically at the BLP stage, and phenocopy <Emphasis Type="Italic">EBF1</Emphasis>-deficiency [<CitationRef CitationID="CR34">34</CitationRef>]. Importantly, <Emphasis Type="Italic">FoxO1</Emphasis>-deficient BLPs have increased transcripts for <Emphasis Type="Italic">socs2</Emphasis>, reminiscent of Pim-1 overexpression [<CitationRef CitationID="CR30">30</CitationRef>]. Based on our immunophenotyping results, together with previous phenotypic, molecular, and cellular data in the literature database, we hypothesize that dyregulated expression on Pim-1, driven by <Emphasis Type="Italic">Eμ</Emphasis>, impairs lymphoid/early B cell differentiation through upregulation of SOCS proteins and inactivation of FoxO1. Upregulation of SOCS proteins inhibits STAT5 mediated B cell differentiation leading to upregulation of EBF1. Inactivation of FoxO1 impairs the global transcriptional network orchestrated by E2A, EBF1, and FoxO1 that directs the early program of B lineage gene expression, requisite for B cell differentiation. In contrast, loss of Pim-1, would be predicted to suppress SOCS protein expression and stabilize FoxO1, favoring B cell developmental potential, providing an explanation for the slight, but not statistically significant, increase in BLP and Pre-Pro-B cells we observed in <Emphasis Type="Italic">pim1-/-</Emphasis> mice. We note that additional studies are required to determine if this molecular explanation is valid.</Para>
              <Para ID="Par20">The goal of this project was to investigate the role of Pim-1 in early lymphoid/B cell development. However, we also found reductions in numbers of HSC, MPP, CMP, and GMP in <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg mice. An, et al., reported an increase in frequencies and numbers of LSK<Superscript>+</Superscript> cells in <Emphasis Type="Italic">vav-Pim1Tg</Emphasis> mice, whereas we report decreased frequencies and numbers of LSK<Superscript>+</Superscript> cells in <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg mice [<CitationRef CitationID="CR16">16</CitationRef>]. The overall decrease in LSK<Superscript>+</Superscript> cells was the basis of the decreased numbers of HSCs and MPPs, as frequencies of CD150<Superscript>+</Superscript> CD34<Superscript>−</Superscript> immunophenotypic HSC within the LSK<Superscript>+</Superscript> compartment were actually increased in <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg mice. We believe it unlikely that <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg expression has any functional consequence on HSC biology for two reasons. First, we previously showed that <Emphasis Type="Italic">Eμ</Emphasis> driven reporter expression is confined to CD27<Superscript>+</Superscript> MPPs within the LSK<Superscript>+</Superscript> compartment and HSCs are CD27<Superscript>−</Superscript> [<CitationRef CitationID="CR11">11</CitationRef>, <CitationRef CitationID="CR24">24</CitationRef>, <CitationRef CitationID="CR35">35</CitationRef>]. Second, the frequencies of CD150<Superscript>+</Superscript> CD34<Superscript>−</Superscript> HSCs were substantially increased in <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg mice.</Para>
              <Para ID="Par21">The cellular and/or molecular basis of the inhibitory consequence of <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg expression on numbers of Flt3<Superscript>+</Superscript> MPPs in noteworthy, as Flt3<Superscript>+</Superscript> MPPs are the precursors of CMP and CLP and these hematopoietic subsets were the most sensitive to <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg expression. <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg expression did not impact Flt3<Superscript>+</Superscript> CMP or CLP by altering the expression levels of Flt3. However, Flt3<Superscript>+</Superscript> CMP and CLP were particularly sensitive to <Emphasis Type="Italic">Eμ − Pim1</Emphasis>Tg expression. These findings suggest that overexpression of Pim-1 might negatively impact signaling networks downstream of Flt3 stimulation in Flt3<Superscript>+</Superscript> progenitor subsets, impairing either their proliferation or survival. Regardless of the mechanism, differentiating CMP and CLP overcome the inhibitory effects and their downstream progeny are refractory to sustained expression of Pim-1. Overexpression of Pim-1 in myeloid progenitors is likely limited by inactivation of <Emphasis Type="Italic">Eμ</Emphasis> due to lack of expression of critical activators necessary to maintain enhancer activity. It is interesting to note that Pim-1 driven by <Emphasis Type="Italic">vav</Emphasis> regulatory elements was low in mature myeloid cells [<CitationRef CitationID="CR16">16</CitationRef>].</Para>
              <Para ID="Par22">Finally, although our flow cytometry analysis revealed that <Emphasis Type="Italic">Pim1-</Emphasis>deficiency does not provide a molecular explanation for the lymphoid/B cell deficiency in <Emphasis Type="Italic">hoxa9-/-</Emphasis> mice, <Emphasis Type="Italic">pim1-/-</Emphasis> and <Emphasis Type="Italic">hoxa9-/-</Emphasis> mice do share similar phenotypic and functional HSC defects. These observations and reported findings underscore developmental stage specific requirements for Hoxa9 and Pim-1 in hematopoietic development.</Para>
            </Section1>
            <Section1 ID="Sec13">
              <Heading>Conclusions</Heading>
              <Para ID="Par23">The goal of this study was to determine the requirement for Pim-1 in early lymphoid/B cell development. We show that controlled expression of Pim-1 is important in lymphoid/B cell development. High levels of Pim-1 are inhibitory while Pim-1 is dispensable for establishment of lymphoid progenitor and Pre-Pro-B cell pools.</Para>
            </Section1>
            <Section1 ID="Sec14">
              <Heading>Abbreviations</Heading>
              <Para ID="Par24">ALP, all lymphoid progenitors; BCP, B cell precursors; BLP, B lineage progenitors; BM, bone marrow; CMP, common myeloid progenitor; flt3l, Flt3-ligand; GMP, granulocyte-macrophage progenitor; HSCs, hematopoietic stem cells; MEP, megakaryocyte-erythroid progenitor; MPP, multipotent progenitor; PPB, Pre-Pro-B; Tg, transgenic.</Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/12865_2016_Article_152.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Acknowledgments>
              <Heading>Acknowledgements</Heading>
              <SimplePara>
                        <Emphasis Type="Italic">Pim1-/-</Emphasis> mice were provided by Andrew S. Kraft (Medical University of South Carolina) with permission obtained from Anton Berns (Netherlands Cancer Institute). <Emphasis Type="Italic">EμPim-1</Emphasis> transgenic mice were provided by Jung-Hyun Park (Experimental Immunology Branch, NCI, NIH) with permission obtained from Anton Berns. This study was supported by R01 HL096108 to K.L.M.</SimplePara>
              <FormalPara ID="FPar1" RenderingStyle="Style1">
                <Heading>Availability of data and materials</Heading>
                <Para ID="Par25">Not applicable.</Para>
              </FormalPara>
              <FormalPara ID="FPar2" RenderingStyle="Style1">
                <Heading>Authors’ contributions</Heading>
                <Para ID="Par26">KLM conceived and designed the experiments, performed data analysis, made figures and wrote the manuscript. ZX performed experiments, data analysis and contributed to making the figures. KAG maintained the animal colonies and performed experiments. YL provided support for ZX. All authors read and approved the final manuscript.</Para>
              </FormalPara>
              <FormalPara ID="FPar3" RenderingStyle="Style1">
                <Heading>Competing interests</Heading>
                <Para ID="Par27">The authors declare that they have no competing financial interests.</Para>
              </FormalPara>
              <FormalPara ID="FPar4" RenderingStyle="Style1">
                <Heading>Consent for publication</Heading>
                <Para ID="Par28">Not applicable.</Para>
              </FormalPara>
              <FormalPara ID="FPar5" RenderingStyle="Style1">
                <Heading>Ethics approval and consent to participate</Heading>
                <Para ID="Par29">All of the experiments using mice in this study were conducted under guidelines established and approved by the Mayo Clinic Institutional Animal Care and Use Committee.</Para>
              </FormalPara>
            </Acknowledgments>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Dolence</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Gwin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Frank</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Medina</FamilyName>
                  </BibAuthorName>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">Threshold levels of Flt3-ligand are required for the generation and survival of lymphoid progenitors and B-cell precursors</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>324</FirstPage>
                  <LastPage>34</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3MXpvFCjsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.201040710</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>21268003</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3050551</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dolence JJ, Gwin K, Frank E, Medina KL. Threshold levels of Flt3-ligand are required for the generation and survival of lymphoid progenitors and B-cell precursors. Eur J Immunol. 2011;41(2):324–34.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Sitnicka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Bryder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Theilgaard-Monch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Buza-Vidas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Adolfsson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Jacobsen</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool</ArticleTitle>
                  <JournalTitle>Immunity</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>463</FirstPage>
                  <LastPage>72</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XosVKku7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1074-7613(02)00419-3</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>12387740</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sitnicka E, Bryder D, Theilgaard-Monch K, Buza-Vidas N, Adolfsson J, Jacobsen SE. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity. 2002;17(4):463–72.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CW</Initials>
                    <FamilyName>So</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Karsunky</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Passegue</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Cozzio</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IL</Initials>
                    <FamilyName>Weissman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Cleary</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice</ArticleTitle>
                  <JournalTitle>Cancer Cell</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>161</FirstPage>
                  <LastPage>71</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXhvFyrsrk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1535-6108(03)00019-9</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>12620410</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>So CW, Karsunky H, Passegue E, Cozzio A, Weissman IL, Cleary ML. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell. 2003;3(2):161–71.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KA</Initials>
                    <FamilyName>Gwin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MB</Initials>
                    <FamilyName>Shapiro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Dolence</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ZL</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Medina</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Hoxa9 and Flt3 signaling synergistically regulate an early checkpoint in lymphopoiesis</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>191</VolumeID>
                  <FirstPage>745</FirstPage>
                  <LastPage>54</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3sXhtVKgtb%2FL</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.4049/jimmunol.1203294</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23772038</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3702669</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gwin KA, Shapiro MB, Dolence JJ, Huang ZL, Medina KL. Hoxa9 and Flt3 signaling synergistically regulate an early checkpoint in lymphopoiesis. J Immunol. 2013;191:745–54.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HT</Initials>
                    <FamilyName>Cuypers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Selten</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Quint</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Zijlstra</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>Maandag</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Boelens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Wezenbeek</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Melief</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Berns</FamilyName>
                  </BibAuthorName>
                  <Year>1984</Year>
                  <ArticleTitle Language="En">Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region</ArticleTitle>
                  <JournalTitle>Cell</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>141</FirstPage>
                  <LastPage>50</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2cXks1KqtLY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0092-8674(84)90309-X</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>6327049</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, van Wezenbeek P, Melief C, Berns A. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell. 1984;37(1):141–50.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Eichmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Yuan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Breant</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Alitalo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Koskinen</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Developmental expression of pim kinases suggests functions also outside of the hematopoietic system</ArticleTitle>
                  <JournalTitle>Oncogene</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <IssueID>9</IssueID>
                  <FirstPage>1215</FirstPage>
                  <LastPage>24</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXitFeqtb8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.onc.1203355</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>10713710</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Eichmann A, Yuan L, Breant C, Alitalo K, Koskinen PJ. Developmental expression of pim kinases suggests functions also outside of the hematopoietic system. Oncogene. 2000;19(9):1215–24.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Mikkers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Nawijn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Brouwers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Verhoeven</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Jonkers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Berns</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors</ArticleTitle>
                  <JournalTitle>Mol Cell Biol</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <IssueID>13</IssueID>
                  <FirstPage>6104</FirstPage>
                  <LastPage>15</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXls1aqtbo%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1128/MCB.24.13.6104-6115.2004</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15199164</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>480904</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mikkers H, Nawijn M, Allen J, Brouwers C, Verhoeven E, Jonkers J, Berns A. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol. 2004;24(13):6104–15.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Riele</FamilyName>
                    <Particle>te</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>Maandag</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Clarke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hooper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Berns</FamilyName>
                  </BibAuthorName>
                  <Year>1990</Year>
                  <ArticleTitle Language="En">Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>348</VolumeID>
                  <IssueID>6302</IssueID>
                  <FirstPage>649</FirstPage>
                  <LastPage>51</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/348649a0</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>te Riele H, Maandag ER, Clarke A, Hooper M, Berns A. Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature. 1990;348(6302):649–51.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Laird</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NM</Initials>
                    <FamilyName>Lugt</FamilyName>
                    <Particle>van der</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Clarke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Domen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Linders</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>McWhir</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Berns</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hooper</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">In vivo analysis of Pim-1 deficiency</ArticleTitle>
                  <JournalTitle>Nucleic Acids Res</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <IssueID>20</IssueID>
                  <FirstPage>4750</FirstPage>
                  <LastPage>5</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXltFertw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/nar/21.20.4750</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>8233823</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>331501</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Laird PW, van der Lugt NM, Clarke A, Domen J, Linders K, McWhir J, Berns A, Hooper M. In vivo analysis of Pim-1 deficiency. Nucleic Acids Res. 1993;21(20):4750–5.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Domen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NM</Initials>
                    <FamilyName>Lugt</FamilyName>
                    <Particle>van der</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Acton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Laird</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Linders</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Berns</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Pim-1 levels determine the size of early B lymphoid compartments in bone marrow</ArticleTitle>
                  <JournalTitle>J Exp Med</JournalTitle>
                  <VolumeID>178</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>1665</FirstPage>
                  <LastPage>73</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXmt1Cjs7w%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.178.5.1665</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>8228813</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Domen J, van der Lugt NM, Acton D, Laird PW, Linders K, Berns A. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow. J Exp Med. 1993;178(5):1665–73.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Dolence</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KA</Initials>
                    <FamilyName>Gwin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MB</Initials>
                    <FamilyName>Shapiro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Medina</FamilyName>
                  </BibAuthorName>
                  <Year>2014</Year>
                  <ArticleTitle Language="En">Flt3 signaling regulates the proliferation, survival, and maintenance of multipotent hematopoietic progenitors that generate B cell precursors</ArticleTitle>
                  <JournalTitle>Exp Hematol</JournalTitle>
                  <VolumeID>42</VolumeID>
                  <FirstPage>380</FirstPage>
                  <LastPage>93</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC2cXosFarsrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.exphem.2014.01.001</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>24444745</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>4089881</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dolence JJ, Gwin KA, Shapiro MB, Medina KL. Flt3 signaling regulates the proliferation, survival, and maintenance of multipotent hematopoietic progenitors that generate B cell precursors. Exp Hematol. 2014;42:380–93.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>LX</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Goetz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CD</Initials>
                    <FamilyName>Katerndahl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Sakaguchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Farrar</FamilyName>
                  </BibAuthorName>
                  <Year>2010</Year>
                  <ArticleTitle Language="En">A Flt3- and Ras-dependent pathway primes B cell development by inducing a state of IL-7 responsiveness</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>184</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>1728</FirstPage>
                  <LastPage>36</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3cXhsVGltLc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.4049/jimmunol.0903023</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>20065110</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2818872</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Li LX, Goetz CA, Katerndahl CD, Sakaguchi N, Farrar MA. A Flt3- and Ras-dependent pathway primes B cell development by inducing a state of IL-7 responsiveness. J Immunol. 2010;184(4):1728–36.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lilly</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Kraft</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>57</VolumeID>
                  <IssueID>23</IssueID>
                  <FirstPage>5348</FirstPage>
                  <LastPage>55</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXnslGqsr0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9393759</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lilly M, Kraft A. Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells. Cancer Res. 1997;57(23):5348–55.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lilly</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Le</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Holland</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SL</Initials>
                    <FamilyName>Hendrickson</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related</ArticleTitle>
                  <JournalTitle>Oncogene</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>727</FirstPage>
                  <LastPage>32</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XksVKgs74%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>1314369</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lilly M, Le T, Holland P, Hendrickson SL. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related. Oncogene. 1992;7(4):727–32.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Miura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Miura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Nakamura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FW</Initials>
                    <FamilyName>Quelle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Witthuhn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JN</Initials>
                    <FamilyName>Ihle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Aoki</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>84</VolumeID>
                  <IssueID>12</IssueID>
                  <FirstPage>4135</FirstPage>
                  <LastPage>41</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXislShtrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>7527668</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Miura O, Miura Y, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood. 1994;84(12):4135–41.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>An</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YW</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Mahajan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JN</Initials>
                    <FamilyName>Kellner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Kraft</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kang</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells</ArticleTitle>
                  <JournalTitle>Stem Cells</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>1202</FirstPage>
                  <LastPage>12</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3sXps1Gjurc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/stem.1369</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23495171</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3664117</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>An N, Lin YW, Mahajan S, Kellner JN, Wang Y, Li Z, Kraft AS, Kang Y. Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells. Stem Cells. 2013;31(6):1202–12.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HJ</Initials>
                    <FamilyName>Lawrence</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Christensen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Fong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YL</Initials>
                    <FamilyName>Hu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Weissman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Sauvageau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RK</Initials>
                    <FamilyName>Humphries</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Largman</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>106</VolumeID>
                  <IssueID>12</IssueID>
                  <FirstPage>3988</FirstPage>
                  <LastPage>94</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXht12ktrrO</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood-2005-05-2003</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16091451</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>1895111</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lawrence HJ, Christensen J, Fong S, Hu YL, Weissman I, Sauvageau G, Humphries RK, Largman C. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood. 2005;106(12):3988–94.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>YL</Initials>
                    <FamilyName>Hu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Passegue</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Fong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Largman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HJ</Initials>
                    <FamilyName>Lawrence</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Evidence that the Pim1 kinase gene is a direct target of HOXA9</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>109</VolumeID>
                  <IssueID>11</IssueID>
                  <FirstPage>4732</FirstPage>
                  <LastPage>8</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2sXmt1Ogtbw%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood-2006-08-043356</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17327400</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>1885524</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hu YL, Passegue E, Fong S, Largman C, Lawrence HJ. Evidence that the Pim1 kinase gene is a direct target of HOXA9. Blood. 2007;109(11):4732–8.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Linowes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Ligons</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Nam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Hong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HR</Initials>
                    <FamilyName>Keller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Tai</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Luckey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Park</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Pim1 permits generation and survival of CD4+ T cells in the absence of gammac cytokine receptor signaling</ArticleTitle>
                  <JournalTitle>Eur J Immunol</JournalTitle>
                  <VolumeID>43</VolumeID>
                  <IssueID>9</IssueID>
                  <FirstPage>2283</FirstPage>
                  <LastPage>94</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3sXpvVemtbY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/eji.201242686</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23712827</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Linowes BA, Ligons DL, Nam AS, Hong C, Keller HR, Tai X, Luckey MA, Park JH. Pim1 permits generation and survival of CD4+ T cells in the absence of gammac cytokine receptor signaling. Eur J Immunol. 2013;43(9):2283–94.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lohuizen</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Verbeek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Krimpenfort</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Domen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Saris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Radaszkiewicz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Berns</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors</ArticleTitle>
                  <JournalTitle>Cell</JournalTitle>
                  <VolumeID>56</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>673</FirstPage>
                  <LastPage>82</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0092-8674(89)90589-8</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>2537153</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>van Lohuizen M, Verbeek S, Krimpenfort P, Domen J, Saris C, Radaszkiewicz T, Berns A. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell. 1989;56(4):673–82.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Gwin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Dolence</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MB</Initials>
                    <FamilyName>Shapiro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Medina</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Differential requirement for Hoxa9 in the development and differentiation of B, NK, and DC-lineage cells from Flt3+ multipotential progenitors</ArticleTitle>
                  <JournalTitle>BMC Immunol</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>5</FirstPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3sXjtVKhs7o%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1186/1471-2172-14-5</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23363389</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3565875</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gwin K, Dolence JJ, Shapiro MB, Medina KL. Differential requirement for Hoxa9 in the development and differentiation of B, NK, and DC-lineage cells from Flt3+ multipotential progenitors. BMC Immunol. 2013;14:5.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KT</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Baird</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JY</Initials>
                    <FamilyName>Ahn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Meltzer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lilly</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Levis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Small</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>105</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>1759</FirstPage>
                  <LastPage>67</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhsVGjs7k%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood-2004-05-2006</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>15498859</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kim KT, Baird K, Ahn JY, Meltzer P, Lilly M, Levis M, Small D. Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival. Blood. 2005;105(4):1759–67.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Medina</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SN</Initials>
                    <FamilyName>Tangen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LM</Initials>
                    <FamilyName>Seaburg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Thapa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KA</Initials>
                    <FamilyName>Gwin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VS</Initials>
                    <FamilyName>Shapiro</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Separation of plasmacytoid dendritic cells from B-cell-biased lymphoid progenitor (BLP) and Pre-pro B cells using PDCA-1</ArticleTitle>
                  <JournalTitle>PLoS ONE</JournalTitle>
                  <VolumeID>8</VolumeID>
                  <IssueID>10</IssueID>
                  <FirstPage>e78408</FirstPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3sXhslClur%2FO</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1371/journal.pone.0078408</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>24205225</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3813560</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Medina KL, Tangen SN, Seaburg LM, Thapa P, Gwin KA, Shapiro VS. Separation of plasmacytoid dendritic cells from B-cell-biased lymphoid progenitor (BLP) and Pre-pro B cells using PDCA-1. PLoS ONE. 2013;8(10):e78408.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Medina</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KP</Initials>
                    <FamilyName>Garrett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LF</Initials>
                    <FamilyName>Thompson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MI</Initials>
                    <FamilyName>Rossi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Payne</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Kincade</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen</ArticleTitle>
                  <JournalTitle>Nat Immunol</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <IssueID>8</IssueID>
                  <FirstPage>718</FirstPage>
                  <LastPage>24</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXlslGisbk%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/90659</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>11477408</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Medina KL, Garrett KP, Thompson LF, Rossi MI, Payne KJ, Kincade PW. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol. 2001;2(8):718–24.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TC</Initials>
                    <FamilyName>Meeker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Nagarajan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>ar-Rushdi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Rovera</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Huebner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Croce</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Characterization of the human PIM-1 gene: a putative proto-oncogene coding for a tissue specific member of the protein kinase family</ArticleTitle>
                  <JournalTitle>Oncogene Res</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>87</FirstPage>
                  <LastPage>101</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3cXitFWksr8%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>3329711</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Meeker TC, Nagarajan L, ar-Rushdi A, Rovera G, Huebner K, Croce CM. Characterization of the human PIM-1 gene: a putative proto-oncogene coding for a tissue specific member of the protein kinase family. Oncogene Res. 1987;1(1):87–101.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Bachmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Kosan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PX</Initials>
                    <FamilyName>Xing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Montenarh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Hoffmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Moroy</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C</ArticleTitle>
                  <JournalTitle>Int J Biochem Cell Biol</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>430</FirstPage>
                  <LastPage>43</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtlCrtr3E</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.biocel.2005.10.010</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16356754</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bachmann M, Kosan C, Xing PX, Montenarh M, Hoffmann I, Moroy T. The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C. Int J Biochem Cell Biol. 2006;38(3):430–43.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Amaravadi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CB</Initials>
                    <FamilyName>Thompson</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">The survival kinases Akt and Pim as potential pharmacological targets</ArticleTitle>
                  <JournalTitle>J Clin Invest</JournalTitle>
                  <VolumeID>115</VolumeID>
                  <IssueID>10</IssueID>
                  <FirstPage>2618</FirstPage>
                  <LastPage>24</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtVygt7vL</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1172/JCI26273</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16200194</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>1236693</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Amaravadi R, Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest. 2005;115(10):2618–24.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Matikainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Sareneva</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Ronni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Lehtonen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Koskinen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Julkunen</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>93</VolumeID>
                  <IssueID>6</IssueID>
                  <FirstPage>1980</FirstPage>
                  <LastPage>91</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhvFSmtbc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>10068671</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Matikainen S, Sareneva T, Ronni T, Lehtonen A, Koskinen PJ, Julkunen I. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood. 1999;93(6):1980–91.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Block</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>NT</Initials>
                    <FamilyName>Hanke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EA</Initials>
                    <FamilyName>Maine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AF</Initials>
                    <FamilyName>Baker</FamilyName>
                  </BibAuthorName>
                  <Year>2012</Year>
                  <ArticleTitle Language="En">IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines</ArticleTitle>
                  <JournalTitle>Pancreas</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>773</FirstPage>
                  <LastPage>81</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC38XhtFGjt7fL</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>22273698</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3337960</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1097/MPA.0b013e31823cdd10</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Block KM, Hanke NT, Maine EA, Baker AF. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines. Pancreas. 2012;41(5):773–81.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>KJ</Initials>
                    <FamilyName>Peltola</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Paukku</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TL</Initials>
                    <FamilyName>Aho</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Ruuska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Silvennoinen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Koskinen</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>103</VolumeID>
                  <IssueID>10</IssueID>
                  <FirstPage>3744</FirstPage>
                  <LastPage>50</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjvF2iur4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood-2003-09-3126</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>14764533</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Peltola KJ, Paukku K, Aho TL, Ruuska M, Silvennoinen O, Koskinen PJ. Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3. Blood. 2004;103(10):3744–50.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BM</Initials>
                    <FamilyName>Iritani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KA</Initials>
                    <FamilyName>Forbush</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Farrar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Perlmutter</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Control of B cell development by Ras-mediated activation of Raf</ArticleTitle>
                  <JournalTitle>Embo J</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <IssueID>23</IssueID>
                  <FirstPage>7019</FirstPage>
                  <LastPage>31</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXisVChtQ%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1093/emboj/16.23.7019</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9384581</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>1170305</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Iritani BM, Forbush KA, Farrar MA, Perlmutter RM. Control of B cell development by Ras-mediated activation of Raf. Embo J. 1997;16(23):7019–31.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Morishita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Katayama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Sekimizu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tsuruo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Fujita</FamilyName>
                  </BibAuthorName>
                  <Year>2008</Year>
                  <ArticleTitle Language="En">Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>68</VolumeID>
                  <IssueID>13</IssueID>
                  <FirstPage>5076</FirstPage>
                  <LastPage>85</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD1cXnvFOqtbs%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1158/0008-5472.CAN-08-0634</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>18593906</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Cancer Res. 2008;68(13):5076–85.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>YC</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Jhunjhunwala</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Benner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Heinz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Welinder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mansson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Sigvardsson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Hagman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Espinoza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Dutkowski</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2010</Year>
                  <ArticleTitle Language="En">A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate</ArticleTitle>
                  <JournalTitle>Nat Immunol</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <IssueID>7</IssueID>
                  <FirstPage>635</FirstPage>
                  <LastPage>43</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3cXntlSjtrc%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/ni.1891</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>20543837</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2896911</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, Sigvardsson M, Hagman J, Espinoza CA, Dutkowski J et al. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol. 2010;11(7):635–43.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibUnstructured>Mansson R, Welinder E, Ahsberg J, Lin YC, Benner C, Glass CK, Lucas JS, Sigvardsson M, Murre C et al. Positive intergenic feedback circuitry, involving EBF1 and FOXO1, orchestrates B-cell fate. Proc Natl Acad Sci U S A. 2012;109(51):21028–33. doi:<ExternalRef><RefSource>10.1073/pnas.1211427109</RefSource><RefTarget Address="10.1073/pnas.1211427109" TargetType="DOI"/></ExternalRef>.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Wiesmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Phillips</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Mojica</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LJ</Initials>
                    <FamilyName>Pierce</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Searles</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GJ</Initials>
                    <FamilyName>Spangrude</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Lemischka</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Expression of CD27 on murine hematopoietic stem and progenitor cells</ArticleTitle>
                  <JournalTitle>Immunity</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>193</FirstPage>
                  <LastPage>9</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXhslKqsLY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1074-7613(00)80172-7</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>10714685</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wiesmann A, Phillips RL, Mojica M, Pierce LJ, Searles AE, Spangrude GJ, Lemischka I. Expression of CD27 on murine hematopoietic stem and progenitor cells. Immunity. 2000;12(2):193–9.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
